Suppr超能文献

日本新型喹诺酮类药物的兽用情况

Veterinary use of new quinolones in Japan.

作者信息

Nakamura S

机构信息

Bioscience Research Laboratories, Dainippon Pharmaceutical Co., Limited, Osaka, Japan.

出版信息

Drugs. 1995;49 Suppl 2:152-8. doi: 10.2165/00003495-199500492-00025.

Abstract

Five new quinolones are used as veterinary medicines in Japan. Benofloxacin and ofloxacin are orally given in feed or in drinking water for respiratory diseases due to Mycoplasma spp. and Escherichia coli in poultry. Enrofloxacin is subcutaneously, intramuscularly or orally administered to cattle and swine for pneumonia due to Pasteurella spp., Mycoplasma spp. and Actinobacillus pleuropneumoniae and diarrhoea due to E. coli, and is used orally for respiratory diseases in poultry. Danofloxacin is similar to enrofloxacin except that the former is not approved for diarrhoea in cattle and swine. Orbifloxacin is given intramuscularly for pneumonia and diarrhoea in cattle and swine but not for poultry diseases. They are effective and safe in animals, and disappear from edible tissues after appropriate drug withdrawal times. The quinolones are indicated only when first-choice drugs are ineffective, only under the direction of veterinarians and only for periods of less than 5 days. Under these conditions, it appears unlikely that quinolone use in veterinary practice will be detrimental to human chemotherapy.

摘要

在日本,有五种新型喹诺酮类药物被用作兽药。贝诺沙星和氧氟沙星通过饲料或饮水口服给药,用于治疗家禽由支原体属和大肠杆菌引起的呼吸道疾病。恩诺沙星通过皮下、肌肉注射或口服给药用于牛和猪,治疗由巴氏杆菌属、支原体属和胸膜肺炎放线杆菌引起的肺炎以及由大肠杆菌引起的腹泻,并且口服用于治疗家禽的呼吸道疾病。达氟沙星与恩诺沙星类似,只是前者未被批准用于牛和猪的腹泻治疗。奥比沙星通过肌肉注射用于牛和猪的肺炎及腹泻,但不用于家禽疾病。它们在动物体内有效且安全,在适当的停药期后会从可食用组织中消失。喹诺酮类药物仅在首选药物无效时、仅在兽医指导下且仅使用少于5天的情况下使用。在这些条件下,兽医临床使用喹诺酮类药物似乎不太可能对人类化疗产生不利影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验